UBS Asset Management Americas Inc. Sells 126,134 Shares of Aetna Inc (AET)

UBS Asset Management Americas Inc. trimmed its position in shares of Aetna Inc (NYSE:AET) by 5.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,404,104 shares of the company’s stock after selling 126,134 shares during the quarter. UBS Asset Management Americas Inc. owned approximately 0.74% of Aetna worth $433,676,000 as of its most recent SEC filing.

Several other hedge funds have also recently made changes to their positions in AET. Advisory Services Network LLC lifted its stake in shares of Aetna by 16.2% in the second quarter. Advisory Services Network LLC now owns 1,780 shares of the company’s stock worth $270,000 after acquiring an additional 248 shares during the period. Cetera Advisors LLC lifted its stake in shares of Aetna by 3.3% in the fourth quarter. Cetera Advisors LLC now owns 8,715 shares of the company’s stock worth $1,573,000 after acquiring an additional 279 shares during the period. Hartford Investment Management Co. lifted its stake in shares of Aetna by 0.4% in the third quarter. Hartford Investment Management Co. now owns 79,409 shares of the company’s stock worth $12,627,000 after acquiring an additional 291 shares during the period. Essex Financial Services Inc. lifted its stake in shares of Aetna by 2.2% in the fourth quarter. Essex Financial Services Inc. now owns 13,787 shares of the company’s stock worth $2,487,000 after acquiring an additional 298 shares during the period. Finally, Violich Capital Management Inc. lifted its stake in shares of Aetna by 0.4% in the third quarter. Violich Capital Management Inc. now owns 70,375 shares of the company’s stock worth $11,190,000 after acquiring an additional 299 shares during the period. 87.10% of the stock is currently owned by hedge funds and other institutional investors.

AET has been the topic of a number of recent analyst reports. Citigroup lifted their price objective on Aetna from $183.00 to $197.00 and gave the stock a “buy” rating in a research note on Thursday, November 2nd. ValuEngine raised Aetna from a “hold” rating to a “buy” rating in a research note on Sunday, December 31st. Deutsche Bank raised Aetna from a “hold” rating to a “buy” rating and lifted their price objective for the stock from $195.00 to $212.00 in a research note on Monday, January 22nd. Piper Jaffray Companies reaffirmed a “buy” rating and issued a $212.00 price objective on shares of Aetna in a research note on Tuesday, January 30th. Finally, Cowen reaffirmed a “buy” rating and issued a $212.00 price objective on shares of Aetna in a research note on Tuesday, January 30th. Ten investment analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. Aetna currently has an average rating of “Buy” and an average target price of $185.94.

Shares of Aetna Inc (NYSE AET) opened at $178.51 on Friday. The firm has a market capitalization of $58,360.00, a P/E ratio of 29.51, a price-to-earnings-growth ratio of 1.44 and a beta of 0.60. The company has a quick ratio of 0.53, a current ratio of 1.68 and a debt-to-equity ratio of 0.52. Aetna Inc has a 1-year low of $124.83 and a 1-year high of $194.40.

Aetna (NYSE:AET) last released its quarterly earnings data on Tuesday, January 30th. The company reported $1.25 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.18 by $0.07. The firm had revenue of $14.74 billion during the quarter, compared to the consensus estimate of $14.79 billion. Aetna had a return on equity of 21.50% and a net margin of 3.15%. The company’s quarterly revenue was down 6.2% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.08 earnings per share. equities analysts anticipate that Aetna Inc will post 10.99 EPS for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Friday, January 26th. Stockholders of record on Thursday, January 11th were issued a dividend of $0.50 per share. The ex-dividend date was Wednesday, January 10th. This represents a $2.00 annualized dividend and a dividend yield of 1.12%. Aetna’s dividend payout ratio is 33.06%.

TRADEMARK VIOLATION NOTICE: This article was originally posted by StockNewsTimes and is the property of of StockNewsTimes. If you are reading this article on another domain, it was stolen and republished in violation of United States and international copyright and trademark law. The original version of this article can be read at https://stocknewstimes.com/2018/02/17/ubs-asset-management-americas-inc-sells-126134-shares-of-aetna-inc-aet.html.

About Aetna

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Institutional Ownership by Quarter for Aetna (NYSE:AET)

Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply